A highly active angiotensin I-converting enzyme inhibitory peptide KAKW designed based on the role of C-terminal residue, and its antihypertensive effects on spontaneously hypertensive rats.

Hu, Yangting et al.·European journal of medicinal chemistry·2025·
RPEP-114452025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
A highly active angiotensin I-converting enzyme inhibitory peptide KAKW designed based on the role of C-terminal residue, and its antihypertensive effects on spontaneously hypertensive rats.
Published In:
European journal of medicinal chemistry, 290, 117564 (2025)
Database ID:
RPEP-11445

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-11445·https://rethinkpeptides.com/research/RPEP-11445

APA

Hu, Yangting; Xie, Dewei; Chen, Xujun; Li, Peng; Zhao, Li; Gao, Bei; Du, Lei; Xie, Jingli. (2025). A highly active angiotensin I-converting enzyme inhibitory peptide KAKW designed based on the role of C-terminal residue, and its antihypertensive effects on spontaneously hypertensive rats.. European journal of medicinal chemistry, 290, 117564. https://doi.org/10.1016/j.ejmech.2025.117564

MLA

Hu, Yangting, et al. "A highly active angiotensin I-converting enzyme inhibitory peptide KAKW designed based on the role of C-terminal residue, and its antihypertensive effects on spontaneously hypertensive rats.." European journal of medicinal chemistry, 2025. https://doi.org/10.1016/j.ejmech.2025.117564

RethinkPeptides

RethinkPeptides Research Database. "A highly active angiotensin I-converting enzyme inhibitory p..." RPEP-11445. Retrieved from https://rethinkpeptides.com/research/hu-2025-a-highly-active-angiotensin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.